SPDR S&P PHARMA ETF Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 28 Posts
1 2
A Look At Pharma ETFs Post Q4 Results
Article By: Sweta Killa Thursday, February 7, 2019 1:47 PM EDT
The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month. Here they are in detail.
In this article: IHE, XPH, PPH, PJP, FTXH Also: JNJ, PFE, MRK, BMY, LLY
Read
Beaten-Down Pharma ETFs To Buy Post Q3 Results
Article By: Sweta Killa Tuesday, November 6, 2018 2:59 PM EDT
Total earnings for 76.7% of the total healthcare market capitalization are up 11% on revenue growth of 7.2%. The growth rates seem unimpressive when compared with some of the other sectors.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, MRK, PFE
Read
AI And The New Health Care
Article By: John Thomas Friday, September 28, 2018 3:34 AM EDT
The first major industry to be fundamentally disrupted by AI will be health care. The next step in our intellectual evolution will be carried out by AI. By connecting our neocortex to the Internet, we will greatly improve our intelligence.
In this article: BMY, MRK, PFE, XLV, XPH
Read
Q2 Earnings Drive Pharma ETFs Higher
Article By: Sweta Killa Tuesday, August 7, 2018 12:23 PM EDT
Total earnings for 83.5% of the total healthcare market capitalization are up 13.7% on revenue growth of 7.8%.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, LLY, MRK, PFE
Read
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By: Kieran O'Dea Monday, December 25, 2017 8:24 AM EDT
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
In this article: IBB, XBI, XPH, SPY, TEVA, AGN, JNJ, MYL, BMY, BIIB, PFE, MRK, INCY
Read
Pharma ETFs Down Post Q3 Earnings
Article By: Sweta Killa Thursday, November 9, 2017 4:19 PM EDT
The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.
In this article: PJP, IHE, XPH, PPH Also: JNJ, LLY, PFE, MRK, BMY
Read
Q2 Earnings Fail To Impress Pharma ETF
Article By: Sweta Killa Monday, August 7, 2017 4:47 PM EDT
Total earnings for 83.3% of the total healthcare market capitalization are up 6% on revenue growth of 4.1%.
In this article: IHE, PJP, XPH, PPH Also: BMY, JNJ, LLY, MRK, PFE
Read
End-Of-Week Sentiment And Trends
Article By: Douglas Gammons Saturday, April 8, 2017 8:35 AM EDT
It seems as though if you wait for price to confirm then a big portion of the short-term has already been made.
In this article: EWY, XLB, XPH Also: RSX
Read
Vertex Soars On Clinical Data And Boosts Biotech Stocks
Article By: Rod Raynovich Wednesday, March 29, 2017 9:00 PM EDT
Vertex Pharmaceuticals soared over 20% to $108 on released Phase 3 clinical data for their cystic fibrosis drug.
In this article: AET, CI, FBIOX, ALNY, ALXN, IBB, QQQ, REGN, VRTX, XBI, XLV, XPH, GWPH, ANTM, RDUS
Read
Q4 Earnings Faring Well For Pharma ETFs
Article By: Sweta Killa Monday, February 6, 2017 12:51 PM EDT
The Q4 earnings season is faring better than the last few years with not only earnings growth on track to reach the highest level in two years but also total earnings set to create a new quarterly record.
In this article: MRK, PJP, IHE, XPH, PPH Also: JNJ, BMY, LLY, PFE
Read
Top Sector ETFs Of Summer
Article By: Zacks Investment Research Wednesday, September 7, 2016 1:27 AM EDT
Following an outstanding July, August has been lukewarm for U.S. equities. Strengthening Fed rate hike bets and finally tepid job data at the eleventh hour left a last-minute impact on the ETF scorecard for summer.
In this article: SOXX, GDX, SOCL, SIL, XHE, XPH, KBWY, PSAU
Read
E The Best Seasonal Investments For Q3
Article By: E.B. Capital Markets Thursday, June 30, 2016 2:49 PM EDT
Bonds and defensive baskets offer the strongest seasonal tailwinds in Q3.The best industries for Q3 seasonality are biotech, healthcare providers, and software.
In this article: ITE, IBB, QQQ, DIA, IGV, IHF, IYH, LQD, MTK, MUB, SPY, TIP, TLT, XBI, XLK, XLP, XLU, XLV, XPH
Read
E The Daily Shot And Data - June 22, 2016
Article By: Sober Look Wednesday, June 22, 2016 10:12 AM EDT
Capital Economics argues that capital outflows from China have been driven by "Chinese firms paying back external debt." Based on that assumption capital flows out of the country should be ending now.
In this article: BITCOMP, CORN, FXB, GBBEF, KOL, TSLA, JNK, OIL, SPY, UNG, XPH
Read
E The Daily Shot And Data - June 20, 2016
Article By: Sober Look Monday, June 20, 2016 9:38 AM EDT
While job openings in the US are near record levels, the rate of increases in job openings has slowed. When combined with the May payrolls report, there are clearly some downside risks here.
In this article: VRX, FXB, JJC, JYNFF, SPY, XPH, BNO, OIL, UNG
Read
E The Daily Shot And Data - May 9, 2016
Article By: Sober Look Monday, May 9, 2016 9:10 AM EDT
Weaker than expected jobs report resulted in Barclays, Merrill Lynch, and others to revise forecasts for the number of Fed rate hikes in 2016. Most economists now expect only one hike in 2016 (in September) - down from two.
In this article: ENDP, FXA, GLD, OIL, SPY, XPH
Read
Bullish Sentiment Solidifies Even In The Face Of Lofty
Article By: Sabrient Systems Tuesday, May 3, 2016 2:01 PM EDT
The stock market rally from the edge-of-the-cliff reversal on February 12 has continued, and an assault on the all-time highs from almost one year ago (on the S&P 500) now seems plausible.
In this article: SPY, VIX, XSW, PYZ, XPH, IPAY Also: CBS, AAPL, AMZN, NFLX, GDXJ, FB, GOOGL
Read
1 to 16 of 28 Posts
1 2